GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seneca Biopharma Inc (STU:7NS2) » Definitions » Institutional Ownership

Seneca Biopharma (STU:7NS2) Institutional Ownership : 2.34% (As of Jun. 17, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Seneca Biopharma Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Seneca Biopharma's institutional ownership is 2.34%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Seneca Biopharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Seneca Biopharma's Float Percentage Of Total Shares Outstanding is 599.24%.

Seneca Biopharma Institutional Ownership Historical Data

The historical data trend for Seneca Biopharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seneca Biopharma Institutional Ownership Chart

Seneca Biopharma Historical Data

The historical data trend for Seneca Biopharma can be seen below:

2020-06-30 2020-07-31 2020-08-31 2020-09-30 2020-10-31 2020-11-30 2020-12-31 2021-01-31 2021-02-28 2021-03-31
Institutional Ownership 0.35 0.35 0.31 0.28 0.28 0.28 0.51 0.97 2.34 2.34

Seneca Biopharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Seneca Biopharma (STU:7NS2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seneca Biopharma Inc (STU:7NS2) » Definitions » Institutional Ownership
Comparable Companies
KMPH BBI TENX TCON MYMX PHIO DMPI APOP PTIX REXN OCSE:NOVO B ASX:CSL VRTX REGN XKRX:207940 SGEN MRNA ALXN XKRX:068270 INCY
Traded in Other Exchanges
N/A
Address
20271 Goldenrod Lane, Suite 2024, Germantown, MD, USA, 20876
Website
https://www.senecabio.com
Seneca Biopharma Inc is a clinical-stage biopharmaceutical company developing novel treatments for diseases of high unmet medical need. It is focused on the research and development of nervous system therapies based on proprietary human neural stem cells and small molecule compounds.

Seneca Biopharma (STU:7NS2) Headlines

No Headlines